Skip to main content
. 2015 Jan 21;14:9. doi: 10.1186/1475-2891-14-9

Figure 1.

Figure 1

Diagram of randomization of patients with gastric or colorectal cancer to receive an n-3 fatty acid enriched parenteral lipid emulsion or a control parenteral lipid emulsion (MCT/LCT).